ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 65 filers reported holding ENZO BIOCHEM INC in Q3 2021. The put-call ratio across all filers is 3.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q1 2018 | $137,000 | -86.3% | 24,942 | -79.6% | 0.00% | -87.0% |
| Q4 2017 | $997,000 | -27.6% | 122,334 | -7.0% | 0.02% | -28.1% |
| Q3 2017 | $1,377,000 | +44.3% | 131,493 | +52.2% | 0.03% | +45.5% |
| Q2 2017 | $954,000 | -4.8% | 86,402 | -27.8% | 0.02% | -8.3% |
| Q1 2017 | $1,002,000 | +11.0% | 119,681 | -8.1% | 0.02% | +14.3% |
| Q4 2016 | $903,000 | +21.4% | 130,159 | -11.0% | 0.02% | +23.5% |
| Q3 2016 | $744,000 | +26.3% | 146,235 | +48.3% | 0.02% | +13.3% |
| Q2 2016 | $589,000 | – | 98,621 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |